Indaptus Therapeutics Inc [NASDAQ: INDP] traded at a high on 2025-09-26, posting a 6.40 gain after which it closed the day’ session at $3.49.
The results of the trading session contributed to over 14693592 shares changing hands. Over the past one week, the price volatility of Indaptus Therapeutics Inc stands at 43.73% while the volatility over the past one month is 24.62%.
The market cap for INDP stock reached $3.86 million, with 1.11 million shares outstanding and 1.00 million shares in the current float. Compared to the average trading volume of 118.98K shares, INDP reached a trading volume of 14693592 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Indaptus Therapeutics Inc [INDP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INDP shares is $25.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INDP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has INDP stock performed recently?
Indaptus Therapeutics Inc [INDP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.54. With this latest performance, INDP shares dropped by -45.47% in over the last four-week period, additionally sinking by -80.82% over the last 6 months – not to mention a drop of -85.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INDP stock in for the last two-week period is set at 40.47, with the RSI for the last a single of trading hit 1.03, and the three-weeks RSI is set at 0.90 for Indaptus Therapeutics Inc [INDP]. The present Moving Average for the last 50 days of trading for this stock 6.29, while it was recorded at 3.14 for the last single week of trading, and 14.88 for the last 200 days.
Indaptus Therapeutics Inc (INDP) Capital Structure & Debt Analysis
Indaptus Therapeutics Inc (INDP) Efficiency & Liquidity Metrics
Indaptus Therapeutics Inc (INDP) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Indaptus Therapeutics Inc. (INDP) effectively leverages its workforce, generating an average of -$2422857.14 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.75% and a Quick Ratio of 0.75%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Indaptus Therapeutics Inc [INDP]
With the latest financial reports released by the company, Indaptus Therapeutics Inc posted -8.96/share EPS, while the average EPS was predicted by analysts to be reported at -13.16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Indaptus Therapeutics Inc go to 34.36%.
Insider trade positions for Indaptus Therapeutics Inc [INDP]
There are presently around $4.72%, or 5.88%% of INDP stock, in the hands of institutional investors. The top three institutional holders of INDP stocks are: VANGUARD GROUP INC with ownership of 0.26 million shares, which is approximately 3.0355%. INVESTMENT HOUSE LLC, holding 0.1 million shares of the stock with an approximate value of $$0.22 million in INDP stocks shares; and INVESTMENT HOUSE LLC, currently with $$0.13 million in INDP stock with ownership which is approximately 0.7025%.
